Dactinomycin (Compound)

Synonyms:DACTINOMYCIN, actinomycin D, Actinomycin C1, Cosmegen, Actinomycin IV, 50-76-0, Meractinomycin, ActD, ACT D, Dactinomycine [INN-French], Dactinomycinum [INN-Latin], UNII-1CC1JFE158, Dactinomicina [INN-Spanish], Lyovac cosmegen, Dactinomycin D, Oncostatin K, Chounghwamycin B, Actinomycin 7, NCI-C04682, MFCD00005033, Actinomycin Aiv, Actinomycin I, GNF-Pf-2290, MLS001424196, 1CC1JFE158, Actinomycin I1, CHEBI:27666, Actinomycin X 1, Actinomycin A IV, Acto-D, Dilactone actinomycin D acid, Actactinomycin A IV, Actinomycin C(sub1), Dilactone actinomycindioic D acid, NCGC00161622-02, Actinomycin I(sub 1), SMR000469227, DSSTox_CID_31, Actinomycin 11 cosmegen, Cosmegen Lyovac, Lyovac-Cosmegen, CCRIS 9, DSSTox_RID_75330, DSSTox_GSID_20031, HSDB 3220, Dactinomicina, Dactinomycine, Dactinomycinum, Actinomycindioic D acid, dilactone, Antibiotic from Streptomyces parvullus, Actinomycin-(threo-val-pro-sar-meval), ACTINOMYCIN-D, CAS-50-76-0, ACT [antibiotic], X 97, 2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide, AD (VAN), GNF-PF-1977, NSC3053, NSC-3053, Glycopeptide, 4a, 2-amino-4,6-dimethyl-3-oxo-N,N'-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxohexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-3H-phenoxazine-1,9-dicarboxamide, NSC 3053, Dactinomycin [USAN:USP:INN:BAN], EINECS 200-063-6, AI3-26374, UPCMLD-DP055, SCHEMBL3844, CHEMBL1554, cid_457193, DTXSID9020031, UPCMLD-DP055:001, UPCMLD-DP055:002, BDBM43866, HMS2052O17, Tox21_111997, Tox21_202482, BDBM50089528, s8964, AKOS030228553, Tox21_111997_1, CCG-101134, DB00970, NC00384, NCGC00090796-01, NCGC00161622-01, NCGC00260031-01, NCGC00271789-02, 2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide, 3H-Phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-, BP-25384, Specific stereoisomer of N,N'-((2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)-bis(carbonylimino(2-hydroxypropylidene)carbonyliminoisobutylidenecarbonyl-1,2-pyrrolidinediylcarbonyl(methylimino)methylenecarbonyl))bis(N-methyl-L-valine) dilactone, Stereoisomer of N,N'-((2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis(carbonylimino(2-(1-hydroxyethyl)-1-oxo-2,1-ethanediyl)imino(2-(1-methylethyl)-1-oxo-2,1-ethanediyl)-1,2-pyrrolidinediylcarbonyl(methylimino) (1-oxo-2,1-ethanediyl)))bis(N-methyl-L-valine)di-xi-lactone, 15160-EP2272827A1, 15160-EP2275420A1, 15160-EP2280012A2, 15160-EP2281815A1, 15160-EP2289892A1, 15160-EP2292615A1, 15160-EP2295055A2
Pubchem:PUBCHEM:457193
Id:457193
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Dactinomycin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Dactinomycin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Dactinomycin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.